6550-- SARS-COV-2 cobas 6800 INTENT TO SOLE SOURCE
Special Notice Posted
A later notice was posted. The latest for this opportunity is the Limited / Sole Source Justification from . See the latest notice
- Solicitation number
- 36C25622Q0221
- Agency
- Veterans Integrated Service Network 16 Veterans Health Administration, Department of Veterans Affairs
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice from the Department of Veterans Affairs Network Contracting Office intends to award a sole source contract for Roche Cobas 6800 System reagents and consumables. The contract would be for a base period of nine months from February 1, 2022 through September 30, 2022, plus four one-year option periods. It will have firm-fixed pricing and be in accordance with FAR 13.5 Simplified Procedures for Certain Commercial Items.
The purpose of this Special Notice is to notify contractors of the VA's intent to award a sole source contract to Roche for reagents and consumables for the Cobas 6800 System. Responses to this notice must be received by December 17, 2021 and directed to the contracting officer. Only contractors providing these specific items for the listed diagnostic system are eligible to respond. The associated NAICS code is 325413 for In-Vitro Diagnostic Substance Manufacturing, with a small business size standard of 1,250 employees. The Special Notice provides details on the opportunity, with requirements for interested contractors to meet deadlines and instructions for submitting a response.
Notice text
The Department of Veterans Affairs Network Contracting Office (NCO 16), Department of Veterans Affairs, VISN 16, Gulf Coast Veterans Health Care System Medical Center, in accordance with FAR 13.5 Simplified Procedures for Certain Commercial Items, intends to award a firm-fixed price with a base and four 1 year options, for the procurement action of Roche Cobas 6800 System reagents and consumables for the tentative award date of February 1, 2022 (TBA) through September 30, 2022 for a period of nine (8) months and four 1 year options. This notice of intent is not a request for quotations. No solicitation package is available. Any responses to this notice must be received no later than 12:00pm central time December 17, 2021. No telephone inquiries will be accepted. Responses must be directed to the Contracting Officer, Diyonne Williams at diyonne.williams@va.gov.
The associated North American Industrial Classification System (NAICS) code for this procurement is 325413, In-Vitro Diagnostic Substance Manufacturing with a small business size standard of 1250 employees.
Attachments
| File | Type | Posted |
|---|---|---|
| 36C25622Q0221_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 520-22-1-077-0033 - SARS-COV-2 cobas 6800 (VA-22-00019480) | Limited / Sole Source Justification | |
| 6550-- SARS-COV-2 cobas 6800 INTENT TO SOLE SOURCE | Special Notice |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity